Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s […]
Investors sold down the stock roughly 5.5% on a disappointing 2025 guide.Investors sold down the stock roughly 5.5% on a disappointing 2025 guide. Honeywell announced Thursday […]